Comparison of digoxin analysis by high-performance liquid chromatography/post-column derivatization and fluorescence polarization immunoassay

References

• Balzan S., Clerico A., Del Chicca M. G., Montali U., Ghione S. Digoxin-like immunoreactivity in normal human plasma and urine, as detected by a solid-phase radioimmunoassay. Clinical Chemistry 1984; 30: 450–451
   PubMed Web of Science ®Google Scholar
• Bianchi P. Interferences in TDx digoxin assay in dialysis patients. Clinical Chemistry 1986; 32: 2099
   PubMed Web of Science ®Google Scholar
• Clark D. R., Kalman S. M. Dihydrodigoxin: a common metabolite of digoxin in man. Drug Metabolism and Disposition 1974; 2: 148–150
   PubMed Web of Science ®Google Scholar
• Cloix J. F., Crabos M., Grichois M. L., Meyer P. An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies. Canadian Journal of Physiology and Pharmacology 1987; 65: 1522–1527
   PubMed Web of Science ®Google Scholar
• Diamandis E. P., Papanastasiou-Diamandis A., Soldin S. J. Digoxin immunoreactivity in cord and maternal serum and placental extracts. Partial characterization of immunoreactive substances by high-performance liquid chromatography and inhibition of Na+, K+-ATPase. Clinical Biochemistry 1985; 18: 48–55
   PubMed Web of Science ®Google Scholar
• DiPiro J. T., Cote J. R., DiPiro C., Bustrack J. A. Spironolactone interference with digoxin radioimmunoassay in cirrhotic patients. American Journal of Hospital Pharmacy 1980; 37: 1518–1521
   PubMedGoogle Scholar
• Doherty J. E., Kane J. J. Clinical pharmacology of digitalis glycosides. Annual Review of Medicine 1975; 26: 159–171
   PubMed Web of Science ®Google Scholar
• Embree L., McErlane K. M. Development of a high-performance liquid chromatographic post-column fluorogenic assay for digoxin in serum. Journal of Chromatography, Biomedical Communications 1989; 496: 321–334
   PubMed Web of Science ®Google Scholar
• Gault M. H., Kalra J., Longerich L., Dawe M. Digoxigenin biotransformation. Clinical Pharmacology and Therapeutics 1982; 31: 695–704
   PubMed Web of Science ®Google Scholar
• Gibson T. P., Nelson H. A. The question of cumulation of digoxin metabolites in renal failure. Clinical Pharmacology and Therapeutics 1980; 27: 219–223
   PubMed Web of Science ®Google Scholar
• Greenway D. C., Nanji A. A. Falsely increased results for digoxin in sera from patients with liver disease: ten immunoassay kits compared. Clinical Chemistry 1985; 31: 1078–1079
   PubMed Web of Science ®Google Scholar
• Keys P. W. Digoxin. Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring, W. E. Evans, J.J. Schentag, W. J. Jusko. Applied Therapeutics Inc., San Francisco 1980; 319–349
   Google Scholar
• Koren G., Farine D., Grundmann H., Heyes J., Soldin S., Taylor J., MacLeod S. M. Endogenous digoxin-like substance(s) associated with uneventful and high-risk pregnancies. Developmental Pharmacology and Therapeutics 1988; 11: 82–87
   PubMedGoogle Scholar
• Kramer H. J., Pennig J., Klingmuller D., Kipnowski J., Glanzer K., Dusing R. Digoxin-like immunoreacting substance(s) in the serum of patients with chronic uremia. Nephron 1985; 40: 297–302
   PubMed Web of Science ®Google Scholar
• Luchi R. J., Gruber J. W. Unusually large digitalis requirements. American Journal of Medicine 1968; 45: 322–328
   PubMed Web of Science ®Google Scholar
• Nanji A. A., Greenway D. C. Falsely raised plasma digoxin concentrations in liver disease. British Medical Journal 1985; 290: 432–433
   PubMed Web of Science ®Google Scholar
• Nanji A. A., Greenway D. C. Correlation between serum albumin and digoxin-like immunoreactive substance in liver disease. Journal of Clinical Pharmacology 1986; 26: 152–153
   PubMed Web of Science ®Google Scholar
• Oldfield P. R., Singer B. E., Toseland P. A. Digoxin determination in the uremic patient: three immunoassays compared. Clinical Chemistry 1985; 31: 1246
   PubMed Web of Science ®Google Scholar
• Scherrmann J. M., Sandouk P., Guedeney X. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum. Clinical Chemistry 1986 a; 32: 97–100
   PubMed Web of Science ®Google Scholar
• Scherrmann J. M., Sandouk P., Guedeney X. Digitalis-like factors and digoxin pharmacokinetics. Chest 1986 b; 89: 468–469
   PubMed Web of Science ®Google Scholar
• Silber B., Sheiner L. B., Powers J. L., Winter M. E., Sadee W. Spironolactone-associated digoxin radioimmunoassay interference. Clinical Chemistry 1979; 25: 48–50
   PubMed Web of Science ®Google Scholar
• Skogen W. F., Rea M. R., Valdes R. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay. Clinical Chemistry 1987; 33: 401–404
   PubMed Web of Science ®Google Scholar
• Soldin S. J., Stephey C., Giesbrecht E., Harding R. Further problems with digoxin measurement. Clinical Chemistry 1986; 32: 1591
   PubMed Web of Science ®Google Scholar
• Sonobe T., Hasumi S., Yoshino T., Kobayashi Y., Kawata H., Nagai T. Digoxin degradation in acidic dissolution medium. Journal of Pharmaceutical Sciences 1980; 69: 410–413
   PubMed Web of Science ®Google Scholar
• Valdes R., Siegfried B. Digoxin immunoactivity in urine of persons not taking digoxin. Clinical Chemistry 1983; 29: 1166
   Web of Science ®Google Scholar
• Valdes R., Brown B. A., Graves S. W. Variable cross-reactivity of digoxin metabolites in digoxin immunoassays. American Journal of Clinical Pathology 1984; 82: 210–213
   PubMed Web of Science ®Google Scholar
• Wilkins M. R. Endogenous digitalis: a review of the evidence. Trends in Pharmacological Sciences 1985; 6: 286–288
   Web of Science ®Google Scholar
• Yatscoff R. W., Desjardins P. R. E., Dalton J. G. Digoxin-like immunoreactivity in the serum of neonates and uremic patients, as measured in the Abbott TDx. Clinical Chemistry 1984; 30: 588
   PubMed Web of Science ®Google Scholar